Drug-induced interstitial lung disease: Indictment for apixaban

Respir Med Res. 2023 Nov:84:101024. doi: 10.1016/j.resmer.2023.101024. Epub 2023 May 19.

Authors

Thibaut Capron¹, Guillaume Botto², Jean-Jacques Roujon², Jean Miltgen², Henri Berard²

Affiliations

¹ Cabinet de Pneumologie, Elsan - Polyclinique les Fleurs, Ollioules, France. Electronic address: thibaut.capron@gmail.com.
² Cabinet de Pneumologie, Elsan - Polyclinique les Fleurs, Ollioules, France.

PMID: 37734231
DOI: 10.1016/j.resmer.2023.101024

No abstract available

Keywords: Adverse event; Apixaban; Direct oral anticoagulants; Drug-induced interstitial lung disease.

Publication types

Letter

MeSH terms

Anticoagulants*
Humans
Lung Diseases, Interstitial* / chemically induced
Pyrazoles / adverse effects
Warfarin

Substances

apixaban
Anticoagulants
Warfarin
Pyrazoles